RWESLEprednisonehydroxychloroquineBELSLEDAI-2KLupus
…uous therapy, currently the longest retention rate described in RWE.…
11,350articles mentioning institutions
22,378institution mentions
9,137distinct institutions extracted
0%of mentions human-reviewed
All extracted institutions
Showing 1,981–2,040 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
A&E1ACCORD1ADSTILADRIN1AGENAS1AGU1AIC Kijabe Hospital1AKUH1ALERT Comprehensive Specialised Hospital1ALSWH1AMBOSS1ANRS-PREVENIR1ANZCRT1APPAC IV1ATC group C071AZUR-21Aalen University1Agogo Presbyterian Hospital1Albany Medical College1Aliment Pharmacol Ther1Allegheny Health1AllofUS1Alomone Labs1American Dental Association1American Journal of Gastroenterology1American Society of Transplantation1Amiens-Picardie University Hospital1Aneuvas Technologies, Inc1Archambault et al1Arm 31Asociación Latinoamericana para el Estudio del Hígado1AstraZeneca1Atrium Health Carolinas Medical Center1BD Biosciences1BE MOBILE 11BIDMC1BIOME study1BMHI1BSGE1BSU1BabyGel trial1Baxter et al1Beijing1Beijing Friendship Hospital1Beijing Huilongguan Hospital1Benchmark-SLE1BioMedware1BioMere1BornFyne1Boston University Medical Center1Brain Aneurysm Foundation1Brain-Heart team1Brightline1Bristol Myers Squibb1British Menopause Society1BronchUK Registry1Brown University Health Institutional Review Board1C-STACS1CAMP1CANN20211CASEM1
Articles mentioning institutions
11,350 articles · page 610 of 946CEDARlupusbiologic treatmentsRheumatologyWelsh GovernmentNHSBritish Society for Rheumatology
…tient input. To address this, the Welsh Government commissioned CEDAR (Centre for Healthcare Evaluation, Device Assessment and Resear…
NCT06121297SLERese-cel
… enabling an ‘immune reset’ with durable responses. RESET-SLE ( NCT06121297) is a Phase 1/2 trial evaluating the safety and efficacy of res…
UCLHbelimumabvoclosporinObinutuzumab
…, obinutuzumab, and voclosporin in a single UK tertiary centre (UCLH).Methods A retrospective analysis included SLE patients treated…
Spanish rheumatology centersAnifrolumabSLEsystemic lupus erythematosusSLE-DASSLEDASCOVID-19herpes zoster
… of anifrolumab in SLE patients under real-life routine care in Spanish rheumatology centers.Methods Multicenter, ambispective study including SLE patients …
87.3%
GSKbelimumabSLEstandard therapyGSK
…ving remission; this retrospective, observational cohort study (GSK Study 222161) explored predictors of remission in this patient …
SUNFLOWERSLEanifrolumabDORISAstraZenecaAvalere Health
…aïve to conventional immunosuppressants/other biologics.Methods SUNFLOWER is a multinational, single-arm study with a 52-week open-label …
Karolinska InstitutetrheumatologyAI-generated feedback
…-experimental study with 115 sixth-semester medical students at Karolinska Institutet (KI), Sweden. During their clinical rotation within rheumatolog…
University College London HospitalHydroxychloroquineSLESACQsystemic lupus erythematosusHCQLupus
…tional risk factors for flare.Methods SLE patient data from the University College London Hospital Lupus cohort were collected (2020–2025), and SACQ cases were id…
tertiary referral centerHydroxychloroquineSLEsystemic lupus erythematosusHCQCKD
…ods We retrospectively analyzed patients with SLE followed at a tertiary referral center in Japan. Kaplan–Meier survival analysis was used to evaluate H…
Mohammed VI University HospitalSystemic lupus erythematosusantimalarialsSLEsystemic corticosteroidsConventional immunosuppressants
…t age 50 years or older, in the Internal Medicine department at Mohammed VI University Hospital in Marrakesh.Results Among 419 SLE cases, late-onset lupus was …